Status:
ACTIVE_NOT_RECRUITING
Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Health and Medical Research Fund
Conditions:
Chronic Liver Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of mobile chat messaging for reducing alcohol use among patients with chronic liver diseases. ...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Diagnosed with chronic liver disease
- Alcohol Use Disorders Identification Test score ≥8
- Own a smartphone with a mobile instant messaging app installed
- Able to read and communicate in Chinese
Exclusion
- Having a psychiatric or psychological disease or on psychotropic drugs
- Participating in other alcohol reduction or abstinence programmes
- Require emergency or in-patient treatment after consultation
Key Trial Info
Start Date :
October 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06587568
Start Date
October 2 2024
End Date
December 31 2025
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong